Latest Healthcare Research Reports

Tag: head and neck cancer therapeutics market

  • Head And Neck Cancer Therapeutics Market Forecast 2024-2033: Anticipated Size and Growth Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Head And Neck Cancer Therapeutics Market: What Growth Rate is Predicted?

    The market size for therapeutics in head and neck cancer has witnessed a swift expansion in recent years. The market is projected to rise from $1.55 billion in 2023 to $1.73 billion in 2024, with a compound annual growth rate (CAGR) of 11.7%. Factors such as tobacco and alcohol use, human papillomavirus (hpv) infections, environmental factors, and the advancement in treatment methods contributed substantially to the growth during the historical period.

    The market size of therapeutics for head and neck cancer is anticipated to experience swift expansion in the coming years, projected to reach $2.57 billion in 2028 with a compound annual growth rate (CAGR) of 10.4%. The anticipated growth during the forecast duration is due to factors such as advancements in immunotherapy, precision medicine methodologies, campaigns promoting awareness and early diagnosis, as well as the overall global aging demographic. Significant trends expected during the forecast timeframe comprise the growing influence of targeted therapies, the uptake of less invasive surgical techniques, the incorporation of palliative care, investigation into new biomarkers and a move towards patient-focused care models.

    Claim Your Free Sample of the Global Head And Neck Cancer Therapeutics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12426&type=smp

    What Aspects Are Driving the Expansion of the head and neck cancer therapeutics Market?

    The rise in cases of head and neck cancer is predicted to fuel expansion in the head and neck cancer therapeutics market. This type of cancer is characterized by an unregulated growth of cells in the head and neck tissues. As the number of infections continues to increase, there is a further need to improve diagnostic and treatment processes to tackle abnormal cell mutations and cancerous growths. In projections from Cancer Research UK, an independent UK-based cancer research body, it is expected that the rate of head and neck cancer in the UK will escalate by 3% between 2023 to 2025, with mortality rates also expected to rise by 12% within the same period. Consequently, the escalating occurrence of head and neck cancer is catalyzing growth in the head and neck cancer therapeutics market.

    What Are the Significant Segments of the Head And Neck Cancer Therapeutics Market?

    1) By Type: Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors

    2) By Route Of Administration: Injectable, Oral

    3) By Distribution Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies

    4) By Application: Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Other Applications

    What Trends Are Influencing the Evolution of the Head And Neck Cancer Therapeutics Market?

    Major corporations functioning in the head and neck cancer therapeutics industry are focusing their resources on developing new pharmaceutical treatments for patients afflicted with head and neck cancer therapeutics. The term drug treatment pertains to the application of medicinal compounds or drugs to treat, control, or lessen medical conditions, diseases, or symptoms in individuals. For example, in October 2023, Coherus BioSciences Inc., a biopharmaceutical organization based in the US, proclaimed that the FDA had approved its newest drug ‘Loqtorzi’. Also known as toripalimab-tpzi, the FDA permitted the use of this drug in collaboration with cisplatin and gemcitabine as the primary treatment for adults who have been diagnosed with advanced or frequently recurring, locally advanced nasopharyngeal carcinoma. During the trial, fewer than 20% of patients experienced adverse reactions, regardless of whether the treatment was administered as a first-line option or as an isolated therapy.

    Order Now for Fast Delivery of Your Head And Neck Cancer Therapeutics Market Report!

    https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-therapeutics-global-market-report

    Which Geographic Areas Are Influencing the Growth of the Head And Neck Cancer Therapeutics Market?

    North America was the largest region in the head and neck cancer therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Head And Neck Cancer Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the head and neck cancer therapeutics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Head And Neck Cancer Therapeutics Market Include

    1. Head And Neck Cancer Therapeutics Market Executive Summary

    2. Head And Neck Cancer Therapeutics Market Segments

    3. Head And Neck Cancer Therapeutics Market Size And Template Market Growth Rate

    4. Key Head And Neck Cancer Therapeutics Market Trends

    5. Major Head And Neck Cancer Therapeutics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Head And Neck Cancer Therapeutics Market

    26. Top Head And Neck Cancer Therapeutics Companies

    27. Head And Neck Cancer Therapeutics Market Opportunities And Strategies

    28. Head And Neck Cancer Therapeutics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Breast Cancer Drugs Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

    Cancer Diagnostics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

    Cancer biologics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Head And Neck Cancer Therapeutics Market 2023

    5 Key Insights On The Head And Neck Cancer Therapeutics Market 2023

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

    As per The Business Research Company’s Head And Neck Cancer Therapeutics Global Market Report 2023, the head and neck cancer therapeutics market is expected to show significant growth in the forecast period.

    Key insights from the head and neck cancer therapeutics market forecast include:

    1. Market Size

    The global head and neck cancer therapeutics market is projected to increase from $1.38 billion in 2022 to $1.55 billion in 2023, with an 11.8% CAGR. It is anticipated to reach $2.32 billion in 2027, with a 10.7% CAGR.

    1. Major Driver

    The head and neck cancer therapeutics market is poised for growth due to the increasing prevalence of head and neck cancer. Head and neck cancer involves uncontrolled cell growth in the head and neck tissues. For example, Cancer Research UK predicts a 3% rise in head and neck cancer incidence in the UK between 2023 and 2025, with a 12% increase in related deaths during the same period. Consequently, the escalating prevalence of head and neck cancer fuels the head and neck cancer therapeutics market.

    View More On The Head And Neck Cancer Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-therapeutics-global-market-report

    1. Key Trend

    Novel therapeutics development is a prominent trend in the head and neck cancer therapeutics market. Leading companies in this market are focused on creating innovative therapies for head and neck cancer to maintain their market position. For example, in February 2020, Debiopharm, a Swiss pharmaceutical manufacturer, secured regulatory approval and a breakthrough therapy designation from the US Food and Drug Administration for Debio 1143, a pioneering therapy. Debio 1143 is a first-of-its-kind oral apoptosis proteins (IAP) antagonist, designed for the treatment of previously untreated, unresectable, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). It can be used in combination with other treatments and has shown promising Phase II results.

    1. Largest Region

    North America was the largest region in the head and neck cancer therapeutics market in 2022.

    1. Major Players

    Major players in the head and neck cancer therapeutics market are Pfizer Inc., F Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers-Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., Hikma Pharmaceuticals PLC, Clinigen Group plc., Ligand Pharmaceuticals, Acceleron Pharma Inc., Taiho Pharmaceutical Co. Ltd., Boston Biomedical Inc., and AB Science SA.

    Request A Sample Of The Global Head And Neck Cancer Therapeutics Market Report 2023:
    https://www.thebusinessresearchcompany.com/sample_request?id=12426&type=smp

    Key Head And Neck Cancer Therapeutics Market Segments
    The global head and neck cancer therapeutics market is segmented –
    1) By Type: Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors
    2) By Route Of Administration: Injectable, Oral
    3) By Distribution Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
    4) By Application: Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Other Applications

    The Head And Neck Cancer Therapeutics Global Market Report 2023  provides an in-depth analysis on the head and neck cancer therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the head and neck cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

    View More Related Reports –
    Intratumoral Cancer Therapies Global Market Report 2023
    Metastatic Breast Cancer Treatment Global Market Report 2023
    Solid Tumor Cancer Treatment Global Market Report 2023

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/
    Americas +1 3156230293
    Asia +44 2071930708
    Europe +44 2071930708
    Email us at info@tbrc.info
    Follow us on:
    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Comprehensive Analysis On Size, Share, And Drivers Of The Head And Neck Cancer Therapeutics Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Head And Neck Cancer Therapeutics Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The escalating prevalence of head and neck cancer has become a significant driving force behind the advancements in head and neck cancer therapeutics market. Here’s a closer look:

    • Rising Incidence and Need for Improved Treatment: Head and neck cancer, characterized by uncontrolled cell growth in the head and neck tissues, is witnessing a surge in cases. This increase underscores the necessity for enhanced diagnostic and treatment modalities to combat mutations and abnormalities in cancer cells.
    • Projected Growth in Incidence and Mortality: Statistics from Cancer Research UK indicate a projected 3% rise in head and neck cancer cases and a 12% increase in related deaths between 2023 and 2025. Such projections highlight the urgency in addressing this growing healthcare challenge.
    • Key Market Players: Major companies like Pfizer Inc., F Hoffmann-La Roche Ltd., and Merck & Co. Inc. are actively involved in the head and neck cancer therapeutics market, contributing to the development of innovative treatments.

    View More On The Head And Neck Cancer Therapeutics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-therapeutics-global-market-report

    Industry Leaders Drive To Introduce Cutting-Edge Drugs For Head And Neck Cancer
    Leading companies are focused on introducing novel drug treatments for head and neck cancer patients, aiming to revolutionize therapeutic approaches:

    • Innovative Drug Treatments: Efforts by major players such as Coherus BioSciences Inc. have led to the FDA approval of groundbreaking drugs like ‘Loqtorzi’, offering new treatment options for patients with metastatic or recurrent nasopharyngeal carcinoma.
    • Expansion and Acquisition: InvoX Pharma’s acquisition of F-star Therapeutics Inc. for $161 million in March 2023 underscores the industry’s commitment to expanding cancer therapeutics portfolios and catering to a broader consumer base.

    Segmentation and Market Dynamics
    The head and neck cancer therapeutics market is segmented based on various factors, including type, route of administration, distribution channel, and application:

    1. Type: Segments include Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors, and Epidermal Growth Factor Receptor (EGFR) Inhibitors, among others.
    2. Route of Administration: Options include injectable and oral formulations, providing flexibility and convenience in treatment.
    3. Distribution Channel: Retail and Specialty Pharmacies, Hospital Pharmacies, and Online Pharmacies serve as vital channels for delivering therapeutics to patients.
    4. Application: Therapeutic interventions encompass Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, and other specialized applications.

    Regional Insights and Growth Projections

    • North America: Emerged as the largest region in the head and neck cancer therapeutics market in 2023, showcasing significant advancements in treatment modalities and healthcare infrastructure.
    • Asia-Pacific: Expected to witness the fastest growth in the forecast period, driven by factors such as increasing awareness, improving healthcare access, and rising investments in research and development.

    Conclusion
    The head and neck cancer therapeutics market is experiencing rapid growth, fueled by the escalating incidence of head and neck cancer and the continuous efforts of industry leaders to innovate and introduce cutting-edge treatments. With advancements in precision medicine, immunotherapy, and targeted therapies, coupled with a focus on early detection and patient-centric care models, the future holds promising prospects for improving outcomes and quality of life for individuals affected by this debilitating disease.

    Request A Sample Of The Global Head And Neck Cancer Therapeutics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12426&type=smp